Related Experiment Video
Updated: Apr 15, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Host APOBEC3G protein inhibits HCV replication through direct binding at NS3
Yan-Ping Zhu1, Zong-Gen Peng1, Zhou-Yi Wu1
1Laboratory of Antiviral Research, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, 100050, China.
Human APOBEC3G (hA3G) restricts hepatitis C virus (HCV) by binding its NS3 protein, inhibiting viral replication. This interaction, independent of deaminase activity, offers potential for new anti-HCV therapies.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Human APOBEC3G (hA3G) is a known antiviral factor.
- hA3G restricts hepatitis C virus (HCV) replication.
- The precise mechanism of hA3G's anti-HCV action was previously undefined.
Purpose of the Study:
- To elucidate the molecular mechanism by which hA3G inhibits HCV replication.
- To investigate the interaction between hA3G and HCV non-structural protein 3 (NS3).
Main Methods:
- Investigated the direct binding interaction between hA3G and HCV NS3.
- Assessed the impact of hA3G binding on NS3 helicase and NTPase activities.
- Examined hA3G expression levels during HCV infection.
Main Results:
- hA3G directly binds to the C-terminus of HCV NS3.
- This binding inhibits NS3's helicase and NTPase activities, thereby restricting HCV replication.
- The antiviral effect of hA3G against HCV is independent of its cytidine deaminase activity.
- While initially upregulated, hA3G levels decrease during chronic HCV infection, suggesting viral evasion mechanisms.
Conclusions:
- hA3G inhibits HCV replication through direct interaction with NS3, independent of its deaminase function.
- This host-pathogen interaction represents a cellular defense against HCV.
- Understanding this mechanism may lead to the development of novel hA3G-stabilizing anti-HCV agents.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors of Bacterial Protein Synthesis
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Hepatitis
Inhibition of Cdk Activity
Inhibition of CDK Activity

